Industry News (Joint Venture)

Alliance Signed To Develop Gene Delivery for Cancer and Pulmonary Disease

Published in Gene Therapy Weekly, August 12th, 1996

Advanced Therapies Inc., Novato, California, announced that they have entered into a collaborative research and license agreement with Genetic Therapy, Inc. (GTI), Gaithersburg, Maryland.

The collaboration focuses on development of gene therapy products in the areas of cancer and pulmonary disease. Under the terms of the agreement, Advanced Therapies applies its proprietary Artificial Viral Envelope (AVE) technology to the delivery and targeting of GTI's proprietary gene therapy programs. GTI/Sandoz have the exclusive right to market the resulting products worldwide.

"The combination of GTI's gene therapy technology coupled with the drug delivery...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (1996-08-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry